Combined Immunodeficiency
Gene: SIT1
PMID 42128181 reports 1 individual from 1 Finnish family with biallelic loss-of-function SIT1 splice-donor variant presenting with adult‑onset combined immunodeficiency, recurrent Hodgkin lymphoma, T‑cell hyperactivation and impaired CD8⁺ cytotoxicity. Unaffected parents and an unaffected brother were confirmed heterozygote carriers. The variant has a heterozygous frequency 0.35% in the Finnish population. Functional studies show exon 2 skipping, loss of SIT1 protein, hyperactive T‑cell responses, and recapitulation of the phenotype in CRISPR‑Cas9 SIT1‑knockout donor T‑cells, with limited rescue by SIT1 mRNA.Created: 15 Jun 2026, 11:55 a.m. | Last Modified: 15 Jun 2026, 11:55 a.m.
Panel Version: 2.0
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Inborn error of immunity, MONDO:0003778
Publications
48-year-old male patient presenting with recalcitrant warts, two different Hodgkin’s lymphomas at the age of 26 and 39 and combined immunodeficiency. Findings robustly supported by multimodal data including KO cell model and partial rescue of cellular phenotype with knock in. Amber for single proband.
Sources: LiteratureCreated: 1 Jun 2026, 8:07 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
recalcitrant warts; hodgkins lymphoma
Publications
Gene: sit1 has been classified as Red List (Low Evidence).
Gene: sit1 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: SIT1 were changed from recalcitrant warts; hodgkins lymphoma to Inborn error of immunity, MONDO:0003778, SIT1-related
Gene: sit1 has been classified as Amber List (Moderate Evidence).
gene: SIT1 was added gene: SIT1 was added to Combined Immunodeficiency. Sources: Literature Mode of inheritance for gene: SIT1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SIT1 were set to PMID: 42128181 Phenotypes for gene: SIT1 were set to recalcitrant warts; hodgkins lymphoma Review for gene: SIT1 was set to AMBER